Our Areas of Interest
The Immunology and Vaccines Business Unit develops vaccines using a recombinant protein approach. We are interested in exploring collaborations related to the fields of:
- Parasitic Diseases
- Immunological Diseases
- Infectious Diseases
In addition, we have several novel adjuvants that could potentially improve the effectiveness of antigens targeted at any disease.